CDMO Solutions

We provide comprehensive CDMO services encompassing process development, analytical methods, IND-enabling CMC (Chemistry, Manufacturing, and Controls), as well as clinical and commercial manufacturing for viral vector, oncolytic virus, and cell therapy products. Our expertise extends to offering holistic solutions tailored to support the industrialization and commercialization of various products at the Pre-IND stage and beyond.

Through years of dedicated effort, OBiO Technology has built an integrated process development system, supported by a flexible cGMP manufacturing platform, comprehensive quality system and efficient project management. Our experienced team of experts will navigate the industrialization process with you side-by-side.

With our technical expertise in viral vector, oncolytic virus and cell therapy, we will help you to accelerate your product life-cycle from pre-clinical to commercially ready.
CDMO Service
  • Viral Vectors
    • AAV
    • Adenoviral vector for delivery of genes
    • Lentiviral vectors
    • Retroviral vectors
    • Virus like particles (VLPs)
    • AAV Packaging
  • Oncolytic Virus
    • Oncolytic adenoviruses
    • Oncolytic herpes simplex virus
    • Oncolytic vaccinia viruses
    • Oncolytic vesicular stomatitis virus
    • Oncolytic Newcastle disease virus
  • Cell Line
    • Autologous and homologous immunocyte therapies
    • CAR-T Therapy
    • NK Cell Therapy
    • TCR-T Therapy
    • DC Therapy
    • ΓδT Therapy
    • Treg Therapy
    • Stem Cell Therapy
  • Plasmid Nucleotides
    • Plasmid DNA
    • Minicircle plasmids
    • dsDNA
    • ssDNA
    • mRNA drug substance
    • mRNA-LNP finished product
    • Exosomes
Why OBiO?
  • 10+ years of dedication to gene and cell therapy
  • 130 process development projects 230 analytical methods developed
  • Quality-driven team of experts with in-time responding
  • Efficient technology transfer with optimizing process validation
  • Process development versatility for various product needs stages
  • End-to-end regulatory support with side-by-side navigation
Innovation
  • AAVneO™ System
    Next-Generation Capsid Screening Platform
  • OVersatile™ Platform
    Versatility for Various Needs
  • Proprietary Cell Line Development
    High-Yielding Cell Line for Suspension Culture
Request Now
© OBiO Tech, Inc. All Rights Reserved